These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 20961697

  • 1. Proton beam therapy for unresectable malignancies of the nasal cavity and paranasal sinuses.
    Zenda S, Kohno R, Kawashima M, Arahira S, Nishio T, Tahara M, Hayashi R, Kishimoto S, Ogino T.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1473-8. PubMed ID: 20961697
    [Abstract] [Full Text] [Related]

  • 2. Outcome of T4 (International Union Against Cancer Staging System, 7th edition) or recurrent nasal cavity and paranasal sinus carcinoma treated with proton beam.
    Fukumitsu N, Okumura T, Mizumoto M, Oshiro Y, Hashimoto T, Kanemoto A, Hashii H, Ohkawa A, Moritake T, Tsuboi K, Tabuchi K, Wada T, Hara A, Sakurai H.
    Int J Radiat Oncol Biol Phys; 2012 Jun 01; 83(2):704-11. PubMed ID: 22099036
    [Abstract] [Full Text] [Related]

  • 3. Malignancies of the nasal cavity and paranasal sinuses: long-term outcome with conventional or three-dimensional conformal radiotherapy.
    Dirix P, Nuyts S, Geussens Y, Jorissen M, Vander Poorten V, Fossion E, Hermans R, Van den Bogaert W.
    Int J Radiat Oncol Biol Phys; 2007 Nov 15; 69(4):1042-50. PubMed ID: 17570610
    [Abstract] [Full Text] [Related]

  • 4. Proton beam therapy as a nonsurgical approach to mucosal melanoma of the head and neck: a pilot study.
    Zenda S, Kawashima M, Nishio T, Kohno R, Nihei K, Onozawa M, Arahira S, Ogino T.
    Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):135-9. PubMed ID: 20950948
    [Abstract] [Full Text] [Related]

  • 5. [Malignomas of the nasal cavity and the paranasal sinuses: clinical characteristics, therapy and prognosis of different tumor types].
    Euteneuer S, Sudhoff H, Bernal-Sprekelsen M, Theegarten D, Dazert S.
    Laryngorhinootologie; 2004 Jan 01; 83(1):33-9. PubMed ID: 14740304
    [Abstract] [Full Text] [Related]

  • 6. Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
    Hoppe BS, Nelson CJ, Gomez DR, Stegman LD, Wu AJ, Wolden SL, Pfister DG, Zelefsky MJ, Shah JP, Kraus DH, Lee NY.
    Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):763-9. PubMed ID: 18395361
    [Abstract] [Full Text] [Related]

  • 7. Intensity-modulated radiotherapy for tumors of the nasal cavity and paranasal sinuses: clinical outcomes and patterns of failure.
    Wiegner EA, Daly ME, Murphy JD, Abelson J, Chapman CH, Chung M, Yu Y, Colevas AD, Kaplan MJ, Fischbein N, Le QT, Chang DT.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):243-51. PubMed ID: 22019239
    [Abstract] [Full Text] [Related]

  • 8. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement?
    Chen AM, Daly ME, Bucci MK, Xia P, Akazawa C, Quivey JM, Weinberg V, Garcia J, Lee NY, Kaplan MJ, El-Sayed I, Eisele DW, Fu KK, Phillips TL.
    Int J Radiat Oncol Biol Phys; 2007 Sep 01; 69(1):141-7. PubMed ID: 17459609
    [Abstract] [Full Text] [Related]

  • 9. Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.
    Zenda S, Kawashima M, Arahira S, Kohno R, Nishio T, Tahara M, Hayashi R, Akimoto T.
    Int J Clin Oncol; 2015 Jun 01; 20(3):447-54. PubMed ID: 25135461
    [Abstract] [Full Text] [Related]

  • 10. Post-operative intensity-modulated radiotherapy for malignancies of the nasal cavity and paranasal sinuses.
    Dirix P, Nuyts S, Vanstraelen B, Nulens A, Hermans R, Jorissen M, Vander Poorten V, Van den Bogaert W.
    Radiother Oncol; 2007 Dec 01; 85(3):385-91. PubMed ID: 17963908
    [Abstract] [Full Text] [Related]

  • 11. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses.
    Daly ME, Chen AM, Bucci MK, El-Sayed I, Xia P, Kaplan MJ, Eisele DW.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):151-7. PubMed ID: 17189068
    [Abstract] [Full Text] [Related]

  • 12. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.
    Hoppe BS, Stegman LD, Zelefsky MJ, Rosenzweig KE, Wolden SL, Patel SG, Shah JP, Kraus DH, Lee NY.
    Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):691-702. PubMed ID: 17161557
    [Abstract] [Full Text] [Related]

  • 13. Proton-beam therapy for olfactory neuroblastoma.
    Nishimura H, Ogino T, Kawashima M, Nihei K, Arahira S, Onozawa M, Katsuta S, Nishio T.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):758-62. PubMed ID: 17398027
    [Abstract] [Full Text] [Related]

  • 14. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
    Dirix P, Vanstraelen B, Jorissen M, Vander Poorten V, Nuyts S.
    Int J Radiat Oncol Biol Phys; 2010 Nov 15; 78(4):998-1004. PubMed ID: 20338694
    [Abstract] [Full Text] [Related]

  • 15. Malignant tumors of the nasal cavity and paranasal sinuses.
    Katz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB.
    Head Neck; 2002 Sep 15; 24(9):821-9. PubMed ID: 12211046
    [Abstract] [Full Text] [Related]

  • 16. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
    Hoppe BS, Wolden SL, Zelefsky MJ, Mechalakos JG, Shah JP, Kraus DH, Lee N.
    Head Neck; 2008 Jul 15; 30(7):925-32. PubMed ID: 18302261
    [Abstract] [Full Text] [Related]

  • 17. [Management and prognosis of patients with squamous cell carcinomas of the nasal cavity and the paranasal sinuses].
    Pickhard A, Durst F, Staudenmaier R, Reiter R.
    Laryngorhinootologie; 2012 Oct 15; 91(10):627-32. PubMed ID: 22930278
    [Abstract] [Full Text] [Related]

  • 18. Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency.
    Snyers A, Janssens GO, Twickler MB, Hermus AR, Takes RP, Kappelle AC, Merkx MA, Dirix P, Kaanders JH.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1343-51. PubMed ID: 18963535
    [Abstract] [Full Text] [Related]

  • 19. Superselective high-dose cisplatin infusion with concomitant radiotherapy in patients with advanced cancer of the nasal cavity and paranasal sinuses: a single institution experience.
    Homma A, Oridate N, Suzuki F, Taki S, Asano T, Yoshida D, Onimaru R, Nishioka T, Shirato H, Fukuda S.
    Cancer; 2009 Oct 15; 115(20):4705-14. PubMed ID: 19634162
    [Abstract] [Full Text] [Related]

  • 20. Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons.
    Weber DC, Chan AW, Lessell S, McIntyre JF, Goldberg SI, Bussiere MR, Fitzek MM, Thornton AF, Delaney TF.
    Radiother Oncol; 2006 Dec 15; 81(3):243-9. PubMed ID: 17050017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.